Health Catalyst, Inc.
$1.71
The Read: Health Catalyst's stock has historically declined sharply following missed earnings and unconvincing guidance that heightened debt concerns, and even after a slight earnings beat and restructuring plan, shares fell due to investor wariness about execution risks.
Price
Overlays
Panel
HCAT
Hover to view data
No Data